# OnCo record claire-harrison (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/claire-harrison/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "claire-harrison" ;
  schema:name "Claire Harrison"@en ;
  schema:description "Led COMFORT-II, which established ruxolitinib as the first drug for myelofibrosis, and most UK MPN trials since."@en ;
  schema:url <https://onco.cc/people/claire-harrison/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Harrison%20CN%5BAuthor%5D%20myelofibrosis%20ruxolitinib> ;
  onco:tag "mpn", "jak-inhibitor", "uk" ;
  schema:jobTitle "Professor of Myeloproliferative Neoplasms and Clinical Director of Haematology, Guy's and St Thomas' NHS Foundation Trust" ;
  onco:cancers <https://onco.cc/cancers/myeloproliferative-neoplasms/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:institutions <https://onco.cc/institutions/guys-st-thomas/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-comfort-1-ruxolitinib-myelofibrosis-nejm-2012/>, <https://onco.cc/key-papers/paper-momentum-momelotinib-lancet-2023/> ;
  onco:journals <https://onco.cc/journals/blood/> ;
  schema:affiliation <https://onco.cc/institutions/guys-st-thomas/> .